N
TMO icon

Natixis’s Thermo Fisher Scientific TMO Stock Holding History

Natixis’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$3K – 1342
2022
Q3 		$3K Buy
5
+3
+150% +$1.68K ﹤0.01% 1042
2022
Q2 		$1K Buy
+2
New +$1.1K ﹤0.01% 1113

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Natixis's TMO Position: Q1 2026 in Review

Natixis increased its Thermo Fisher Scientific (TMO) stake by 20% in Q1 2026, buying an estimated $6.03M and bringing the position to 66,593 shares worth $32.7M. The position accounts for 0.12% of the portfolio, ranked #128.

Natixis first reported a position in TMO in Q4 2013 and has held it in 41 quarters since. The position peaked at $182M in Q3 2018. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Natixis held 66,593 shares of Thermo Fisher Scientific worth $32.7M as of Q1 2026.
  • Natixis bought 11,114 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.03M.
  • Thermo Fisher Scientific made up 0.12% of Natixis's portfolio in Q1 2026, its #128 holding.
  • Natixis first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 41 quarters since.
  • Natixis's Thermo Fisher Scientific position peaked at $182M in Q3 2018.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.